rs1555972516

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6BP7

The NM_001184880.2(PCDH19):​c.3405A>G​(p.Lys1135Lys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000273 in 1,097,910 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: not found (cov: 22)
Exomes 𝑓: 0.0000027 ( 0 hom. 1 hem. )

Consequence

PCDH19
NM_001184880.2 synonymous

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: 1.27

Publications

0 publications found
Variant links:
Genes affected
PCDH19 (HGNC:14270): (protocadherin 19) The protein encoded by this gene is a member of the delta-2 protocadherin subclass of the cadherin superfamily. The encoded protein is thought to be a calcium-dependent cell-adhesion protein that is primarily expressed in the brain. Mutations in this gene on human chromosome X are associated with sporadic infantile epileptic encephalopathy and to a female-restricted form of epilepsy (EFMR; also known as PCDH19RE). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2017]
PCDH19 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 9
    Inheritance: XL, Unknown Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • X-linked complex neurodevelopmental disorder
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • Dravet syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.59).
BP6
Variant X-100296319-T-C is Benign according to our data. Variant chrX-100296319-T-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 436167.
BP7
Synonymous conserved (PhyloP=1.27 with no splicing effect.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PCDH19NM_001184880.2 linkc.3405A>G p.Lys1135Lys synonymous_variant Exon 6 of 6 ENST00000373034.8 NP_001171809.1 Q8TAB3-1
PCDH19NM_001105243.2 linkc.3264A>G p.Lys1088Lys synonymous_variant Exon 5 of 5 NP_001098713.1 Q8TAB3-2B3KU71
PCDH19NM_020766.3 linkc.3261A>G p.Lys1087Lys synonymous_variant Exon 5 of 5 NP_065817.2 Q8TAB3-3B3KU71

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PCDH19ENST00000373034.8 linkc.3405A>G p.Lys1135Lys synonymous_variant Exon 6 of 6 1 NM_001184880.2 ENSP00000362125.4 Q8TAB3-1
PCDH19ENST00000255531.8 linkc.3264A>G p.Lys1088Lys synonymous_variant Exon 5 of 5 1 ENSP00000255531.7 Q8TAB3-2
PCDH19ENST00000420881.6 linkc.3261A>G p.Lys1087Lys synonymous_variant Exon 5 of 5 1 ENSP00000400327.2 Q8TAB3-3
PCDH19ENST00000464981.1 linkn.-19A>G upstream_gene_variant 3 ENSP00000479805.1 A0A1Y8EN23

Frequencies

GnomAD3 genomes
Cov.:
22
GnomAD4 exome
AF:
0.00000273
AC:
3
AN:
1097910
Hom.:
0
Cov.:
30
AF XY:
0.00000275
AC XY:
1
AN XY:
363270
show subpopulations
African (AFR)
AF:
0.0000379
AC:
1
AN:
26399
American (AMR)
AF:
0.00
AC:
0
AN:
35207
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19380
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30205
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54138
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40529
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4137
European-Non Finnish (NFE)
AF:
0.00000119
AC:
1
AN:
841824
Other (OTH)
AF:
0.0000217
AC:
1
AN:
46091
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
22
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1
Sep 17, 2015
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Developmental and epileptic encephalopathy, 9 Benign:1
Aug 19, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.59
CADD
Benign
6.7
DANN
Benign
0.77
PhyloP100
1.3

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1555972516; hg19: chrX-99551317; API